Nordea Investment Management AB Increases Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Nordea Investment Management AB grew its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 4.4% in the ...
Brokers Issue Forecasts for CRSP FY2024 Earnings
Brookline Capital Management boosted their FY2024 earnings per share estimates for CRISPR Therapeutics in a research note issued on Monday, January 6th. Brookline Capital Management analyst L. Cann ...
1 growth stock that could soar 105%, according to Wall Street experts
This Fool has his eye on an innovative growth stock that has plunged by 80% since early 2021. But what is so special about it ...
Gene editing stocks drop as Intellia announces layoffs
Intellia Therapeutics (NTLA) stock falls, sending its gene editing rivals lower, as Wall Street reacts to its latest layoff ...
precisionmedicineonline20h
Intellia Cuts AATD Gene Insertion Program, 27 Percent of Workforce in Strategic Reorganization
These moves will enable the gene-editing company to focus resources on late-stage programs as it aims to launch a commercial product by 2027, it said.
STAT22h
Intellia cuts 27% of staff, in the latest wave of gene-editing layoffs
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
The Pharma Letter23h
CRISPR gene editing company cuts program and jobs
Intellia Therapeutics, a US gene editing company developing CRISPR-based therapies, announced late Thursday its strategic ...